Hypertension attenuates the link of osteoprotegerin to reduced baroreflex sensitivity in type 2 diabetes mellitus patients on oral antidiabetic and antihypertensive therapy – a cross sectional study

PURPOSE: Decreased baroreflex sensitivity (BRS) has been shown to be a marker of cardiovascular (CV) risk. In the present study, the difference in CV risk biomarkers in type 2 diabetes (T2D) patients receiving oral antidiabetic drugs (OAD) with and without hypertension has been assessed. MATERIALS A...

Descripción completa

Detalles Bibliográficos
Autores principales: Sailaja, A. Naga, Nanda, Nivedita, Suryanarayana, B. S., Pal, G. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463832/
https://www.ncbi.nlm.nih.gov/pubmed/36085061
http://dx.doi.org/10.1186/s12902-022-01137-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463832/
https://www.ncbi.nlm.nih.gov/pubmed/36085061
http://dx.doi.org/10.1186/s12902-022-01137-w

Ejemplares similares